Daniella Beckman's Net Worth

$1.14 Million

Estimate Recalculated May 10, 2024 03:07PM EST

Who is Daniella Beckman?

Daniella Beckman has an estimated net worth of $1.14 Million. This is based on reported shares across multiple companies, which include Tango Therapeutics, Inc., Vor Biopharma Inc., Translate Bio, Inc., 5:01 Acquisition Corp., Blueprint Medicines Corp, and IDENIX PHARMACEUTICALS INC.

SEC CIK

Daniella Beckman's CIK is 0001513422

Past Insider Trading and Trends

2021 was Daniella Beckman's most active year for acquiring shares with 5 total transactions. Daniella Beckman's most active month to acquire stocks was the month of May. 2014 was Daniella Beckman's most active year for disposing of shares, totalling 8 transactions. Daniella Beckman's most active month to dispose stocks was the month of July. 2021 saw Daniella Beckman paying a total of $0.00 for 427,785 shares, this is the most they've acquired in one year. In 2014 Daniella Beckman cashed out on 408,500 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tango Therapeutics, Inc. (TNGX) Snapshot price: $12.72

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.74%
-3.73K
$12.59
-$46,899.62
132.4K
Feb 6 - Feb 7
Form 4
∞
39.41K
—
—
39.41K
Feb 1
Form 4
+51.42%
32.84K
—
—
96.71K
Mar 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Aug 12
Form 3
—
0
—
—
0
No matching records found

Vor Biopharma Inc. (VOR) Snapshot price: $2.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Feb 5
Form 3
—
0
—
—
0
No matching records found

Translate Bio, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 14
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 18
Form 3
—
0
—
—
0
No matching records found

5:01 Acquisition Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 16
Form 3
—
0
—
—
0
No matching records found

Blueprint Medicines Corp (BPMC) Snapshot price: $74.735

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+43.33%
2.6K
—
—
8.6K
Jun 21
Form 4
+76.47%
2.6K
—
—
6K
Jun 21
Form 4/A
∞
3.4K
—
—
3.4K
Dec 8
Form 3/A
—
0
—
—
0
No matching records found